Literature DB >> 11684834

Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery.

N Sato1, K Koeda, Y Kimura, K Ikeda, M Ogawa, K Saito, S Endo.   

Abstract

OBJECTIVES: The body's response to stress is comprised of two opposing reactions, namely inflammation and immunosuppression. The balance between these two reactions not only changes over time, but also varies among different cells or organs. Limited information is available regarding the cytokine balance of circulating blood and inflammatory sites after thoracic surgical stress.
DESIGN: The subjects of the present study were 10 patients undergoing esophageal cancer surgery which requires thoracolaparotomic manipulation. The postoperative levels of interleukin (IL)-8, IL-10, IL-1 receptor antagonist (IL-1ra) and soluble tumor necrosis factor receptor I (sTNF-RI) in bronchoalveolar lavage fluids (BALFs) and peripheral blood were measured by enzyme-linked immunosorbent assay. The absolute concentration of cytokines in lower respiratory tract ([cytokine](LRT)) was estimated by using the ratio of urea concentration in BALF and serum.
RESULTS: The levels of these cytokines in peripheral blood peaked within 24 h of start of the surgery (IL-8 85.6 +/- 29.8 pg/ml; IL-10 65.1 +/- 10.6 pg/ml; IL-1ra 2,807.8 +/- 652.8 pg/ml, and sTNF-RI 3,996.3 +/- 380.1 pg/ml). The level of [IL-8](LRT) immediately after surgery was approximately 20 times higher than that in peripheral blood, and the level of [IL-1ra](LRT) was approximately 4 times higher. In contrast, the level of [IL-10](LRT) immediately after surgery was comparable to that in peripheral blood, but the level of [sTNF RI](LRT) immediately after surgery was approximately one fifth of that in peripheral blood.
CONCLUSIONS: The balance between pro- and anti-inflammatory reactions varies from one part of the body to the next, and changes over time after surgery. The profile of stress-induced pro-inflammatory cytokines and anti-inflammatory cytokines should be analyzed further to establish appropriate and effective cytokine modulatory therapeutic approaches. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684834     DOI: 10.1159/000049718

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  7 in total

1.  Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer.

Authors:  Nobuhiro Sato; Keisuke Koeda; Kenichiro Ikeda; Yusuke Kimura; Kiichi Aoki; Takeshi Iwaya; Yuji Akiyama; Kaoru Ishida; Kazuyoshi Saito; Shigeatsu Endo
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

2.  Cytokine Response in the Pleural Fluid and Blood in Minimally Invasive and Open Esophagectomy.

Authors:  T Delko; D I Watson; B Beck-Schimmer; A Immanuel; D J Hussey; U Zingg
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

3.  Group IIA-soluble phospholipase A2 levels in patients with infections after esophageal cancer surgery.

Authors:  Masaaki Ogawa; Nobuhiro Sato; Shigeatsu Endo; Masahiro Kojika; Yasunori Yaegashi; Yusuke Kimura; Kenichiro Ikeda; Takeshi Iwaya
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Optimal period for the prophylactic administration of neutrophil elastase inhibitor for patients with esophageal cancer undergoing esophagectomy.

Authors:  Makoto Iwahashi; Mikihito Nakamori; Masaki Nakamura; Toshiyasu Ojima; Teiji Naka; Hiroki Yamaue
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

Review 5.  Acute respiratory distress syndrome after pulmonary resection.

Authors:  Takuro Kometani; Tatsuro Okamoto; Shigetoshi Yoshida; Ichiro Yoshino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-06-18

6.  The beta agonist lung injury trial prevention. A randomized controlled trial.

Authors:  Gavin D Perkins; Simon Gates; Daniel Park; Fang Gao; Chris Knox; Ben Holloway; Daniel F McAuley; James Ryan; Joseph Marzouk; Matthew W Cooke; Sarah E Lamb; David R Thickett
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

7.  Vitamin D to Prevent Lung Injury Following Esophagectomy-A Randomized, Placebo-Controlled Trial.

Authors:  Dhruv Parekh; Rachel C A Dancer; Aaron Scott; Vijay K D'Souza; Phillip A Howells; Rahul Y Mahida; Jonathan C Y Tang; Mark S Cooper; William D Fraser; LamChin Tan; Fang Gao; Adrian R Martineau; Olga Tucker; Gavin D Perkins; David R Thickett
Journal:  Crit Care Med       Date:  2018-12       Impact factor: 7.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.